Comprehensive analysis of aberrations in pan-cancer, with a focus on prognostic and therapeutic implications by Jaeyun Jung, Jung Yong Hong, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Won Ki Kang, Jeeyun Lee, Sang Yun Ha, Soomin Ahn, Sung Hee Lim, Seung Tae Kim

Get full text

Organ‐Specific Responses to Nivolumab Plus Ipilimumab in Advanced Hepatocellular Carcinoma: A Multicenter, Retrospective Study by Jung Sun Kim, Youngun Kim, Beodeul Kang, Ilhwan Kim, Hyeyeong Kim, Won Suk Lee, Jung Yong Hong, Ho Yeong Lim, Han Sang Kim, Chang Gon Kim, Sanghoon Jung, Chansik An, Chan Kim, Hong Jae Chon

Get full text

Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studies by Richard S. Finn, Kangsheng Gu, Xi Chen, Philippe Merle, Kyung-Hun Lee, Mohamed Bouattour, Peiguo Cao, Wei Wang, Ann-Lii Cheng, Liangjun Zhu, Ho Yeong Lim, Masatoshi Kudo, Yueyin Pan, Ting-Tsung Chang, Julien Edeline, Wei Li, Ping Yang, Chen Li, Jianfeng Li, Abby B. Siegel, Shukui Qin

Get full text

Nanostring-based multigene assay to predict recurrence for gastric cancer patients after surgery. by Jeeyun Lee, Insuk Sohn, In-Gu Do, Kyoung-Mee Kim, Se Hoon Park, Joon Oh Park, Young Suk Park, Ho Yeong Lim, Tae Sung Sohn, Jae Moon Bae, Min Gew Choi, Do Hoon Lim, Byung Hoon Min, Joon Haeng Lee, Poong Lyul Rhee, Jae J Kim, Dong Il Choi, Iain Beehuat Tan, Kakoli Das, Patrick Tan, Sin Ho Jung, Won Ki Kang, Sung Kim

Get full text